2 results
P
patients with newly diagnosed advanced high-grade serous and endometrioid epithelial ovarian cancer (EOC)
I/C
poly(ADP-ribose) polymerase inhibitors (PARPi), placebo
O
progression-free survival (PFS)
P
preterm newborns
I/C
high-flow nasal cannula, continuous positive airway pressure
O
therapeutic failure, nasal trauma
